Latest 30 News in the Life Sciences Industry
PR Newswire Association LLC.
Altesa BioSciences Welcomes Seasoned Biotech Leader Brett Haumann, MBBCh, MBA as Chief Executive Officer
21 Jul 2026
GlobeNewswire
Cincinnati Children's Activated as the Seventh Qualified Treatment Center for ZEVASKYN®
21 Jul 2026
GlobeNewswire
Cadrenal Therapeutics Launches Partnering Process as Its Cardiac Acute Critical Care Assets Advance to Transaction Readiness Following Landmark ISTH Data Presentation
21 Jul 2026
PR Newswire Association LLC.
Precigen to Announce Second Quarter 2026 Financial Results and Provide Business Updates on August 4
21 Jul 2026
PR Newswire Association LLC.
Billions Flow Into Next-Generation Depression Treatments as Pharma Innovation Accelerates
21 Jul 2026
PR Newswire Association LLC.
Avaí Bio and Austrianova Reach Agreement for Insulin-Producing Cells with Internationally Acclaimed Partner to Advance Diabetes Therapy
21 Jul 2026
PR Newswire Association LLC.
WELLGISTICS HEALTH, INC. OFFICIALLY CHANGES CORPORATE NAME TO DATAMEDS AI, INC.
21 Jul 2026
PR Newswire Association LLC.
Luma Health Announces Patient Pipeline, AI-Powered New Patient Acquisition to Turn Ad Spend Into Booked Patient Care
21 Jul 2026
GlobeNewswire
R1 Therapeutics announces commencement of global Phase 2b trial of AP306 for hyperphosphatemia in patients on dialysis
21 Jul 2026
GlobeNewswire
Bluejay Diagnostics Announces Successful Completion of Enrollment in the SYMON-II Multicenter Clinical Validation Study
21 Jul 2026
GlobeNewswire
VYNE Therapeutics Announces 1-for-50 Reverse Stock Split and Provides Update Regarding Special Dividend in Connection with the Proposed Merger with Yarrow Bioscience
21 Jul 2026
PR Newswire Association LLC.
Vesalio Announces Late-Breaking Clinical Trial Presentation of the enVast NATURE Study at the ESC Congress 2026
21 Jul 2026
GlobeNewswire
Jupiter Neurosciences (NASDAQ: JUNS) Signs Definitive Agreement for Exclusive U.S. Rights to ALA-002 in Transaction Valued at Up to $100 Million
21 Jul 2026
PR Newswire Association LLC.
MedSpeed Joins Forces with Am-Tran, Strengthening Presence Across California
21 Jul 2026
PR Newswire Association LLC.
Alebund Pharmaceuticals Announces First Participant Randomized and Dosed in Global Phase IIb Multi-Regional Clinical Trial of AP306 for Hyperphosphatemia
21 Jul 2026
GlobeNewswire
Novo Nordisk takes action to stop multiple misleading national GLP-1 advertising campaigns by Eli Lilly
21 Jul 2026
PR Newswire Association LLC.
The Group Savings Organization (The GSO) Appoints Cheryl Matejka to Board of Advisors
21 Jul 2026
GlobeNewswire
Kraig Biocraft Laboratories CEO Kim Thompson Featured in Just Style, a Leading Global Apparel Industry Trade Publication
21 Jul 2026
PR Newswire Association LLC.
NUTRAFOL UNVEILS THE NEXT GENERATION OF ITS BOOSTER NUTRACEUTICALS
21 Jul 2026
PR Newswire Association LLC.
PBS Biotech Wins 2026 Cell Products Development of the Year Award
21 Jul 2026
PR Newswire Association LLC.
TYBR Health Announces $30 Million Series A Financing to Expand Access to the B3 GEL® System
21 Jul 2026
GlobeNewswire
Tempest Announces Development Collaboration with Senlang Biotechnology for TPST-4003, a CD7-Targeted Next-Generation In Vivo CAR-T
21 Jul 2026
PR Newswire Association LLC.
Surgical Planning Associates Announces Open Platform Access to the HipInsight System® Enabling Technology Platform
21 Jul 2026
GlobeNewswire
Agios Provides Update on Phase 2 Trial of Tebapivat in Sickle Cell Disease
21 Jul 2026
GlobeNewswire
Verrica Pharmaceuticals and Medomie Pharma Enter into Exclusive Distribution, Marketing and Supply Agreement to Commercialize YCANTH® for the Treatment of Molluscum Contagiosum in Israel
21 Jul 2026
GlobeNewswire
Rhythm Pharmaceuticals to Report Second Quarter 2026 Financial Results on Tuesday, August 4, 2026
21 Jul 2026
Upcoming Events All Events
- August 2026
- Online: Biotechgate Digital Partnering August 2026
- September 2026
- Marina Bay Sands: Asia Bio Partnering Forum
- Rockville: BioHealth Capital Region Forum & Investment Conference